Colorectal cancer chemoprevention by trans-resveratrol

Pharmacological Research

Volumn 65, Issue 6, 2012, Pages 584-591

  Juan, M Emília ^a   Alfaras, Irene ^a   Planas, Joana M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Animal models; Clinical trials; Colon cancer; Resveratrol

Indexed keywords

RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE REGULATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DOSE RESPONSE; DRUG TARGETING; FAMILIAL COLON POLYPOSIS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRECANCEROUS CONDITIONS; STILBENES;

EID: 84860290833     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.03.010     Document Type: Review

References (74)

1. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506 (Pubitemid 44136961)
2. H. Li, N. Xia, and U. Förstermann Cardiovascular effects and molecular targets of resveratrol Nitric Oxide 26 2012 102 110
3. J.M. Wu, and T.C. Hsieh Resveratrol: a cardioprotective substance Ann N Y Acad Sci 1215 2011 16 21
4. T. Richard, A.D. Pawlus, M.L. Iglésias, E. Pedrot, P. Waffo-Teguo, and J.M. Mérillonet Neuroprotective properties of resveratrol and derivatives Ann N Y Acad Sci 1215 2011 103 108
5. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W. Beecher Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220 (Pubitemid 127696281)
6. Y. Shukla, and R. Singh Resveratrol and cellular mechanisms of cancer prevention Ann N Y Acad Sci 1215 2011 1 8
7. N. Namasivayam Chemoprevention in experimental animals Ann N Y Acad Sci 1215 2011 60 71
8. M.E. Juan, M.P. Vinardell, and J.M. Planas The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful J Nutr 132 2002 257 260 (Pubitemid 34135604)
9. L.D. Williams, G.A. Burdock, J.A. Edwards, M. Beck, and J. Bausch Safety studies conducted on high-purity trans-resveratrol in experimental animals Food Chem Toxicol 47 2009 2170 2182
10. M.E. Juan, J. Buenafuente, I. Casals, and J.M. Planas Plasmatic levels of trans-resveratrol in rats Food Res Int 35 2002 195 199 (Pubitemid 34161561)
11. C.H. Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, and J.L. Beaudeux Resveratrol bioavailability and toxicity in humans Mol Nutr Food Res 54 2010 7 16
12. T. Walle Bioavailability of resveratrol Ann N Y Acad Sci 1215 2011 9 15
13. I. Alfaras, M. Pérez, M.E. Juan, G. Merino, J.G. Prieto, and J.M. Planas Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice J Agric Food Chem 58 2010 4523 4528
14. M.E. Juan, E. González-Pons, and J.M. Planas Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats J Nutr 140 2010 489 495
15. D. Delmas, E. Solary, and N. Latruffe Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe Curr Med Chem 18 2011 1100 1121
16. M. Ndiaye, R. Kumar, and N. Ahmad Resveratrol in cancer management: where are we and where we go from here Ann N Y Acad Sci 1215 2011 144 149
17. A.J. Watson An overview of apoptosis and the prevention of colorectal cancer Crit Rev Oncol Hematol 57 2006 107 121 (Pubitemid 43139699)
18. M.E. Juan, U. Wenzel, H. Daniel, and J.M. Planas Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells J Agric Food Chem 56 2008 4813 4818 (Pubitemid 351999415)
19. Y.C. Liang, S.H. Tsai, L. Chen, S.Y. Lin-Shiau, and J.K. Lin Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells Biochem Pharmacol 65 2003 1053 1060 (Pubitemid 36349745)
20. M.P. Fuggetta, G. Lanzilli, M. Tricarico, A. Cottarelli, R. Falchetti, and G. Ravagnan Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro J Exp Clin Cancer Res 25 2006 189 193 (Pubitemid 44113862)
21. C. Hope, K. Planutis, M. Planutiene, M.P. Moyer, K.S. Johal, and J. Woo Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention Mol Nutr Food Res 52 2008 S52 S61
22. J. Vanamala, L. Reddivari, S. Radhakrishnan, and C. Tarver Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 10 2010 238
23. Y. Schneider, F. Vincent, B. Duranton, L. Badolo, F. Gossé, and C. Bergmann Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells Cancer Lett 158 2000 85 91 (Pubitemid 30627485)
24. F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines J Nutr 131 2001 2197 2203 (Pubitemid 32720652)
25. S. Ulrich, S.M. Loitsch, O. Rau, A. von Knethen, B. Brüne, and M. Schubert-Zsilavecz Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism Cancer Res 66 2006 7348 7354 (Pubitemid 44197718)
26. D. Delmas, P. Passilly-Degrace, B. Jannin, M. Cherkaoui Malki, and N. Latruffe Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells Int J Mol Med 10 2002 193 199
27. A. Walther, E. Johnstone, C. Swanton, R. Midgley, I. Tomlinson, and D. Kerr Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer 9 2009 489 499
28. P. Salama, and C. Platell Colorectal cancer stem cells ANZ J Surg 79 2009 697 702
29. S. Imai A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis Pharmacol Res 62 2010 42 47
30. J.A. Baur Resveratrol, sirtuins, and the promise of a DR mimetic Mech Ageing Dev 131 2010 261 269
31. S.J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams, and H. Luo Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 148 2012 421 433
32. R. Firestein, G. Blander, S. Michan, P. Oberdoerffer, S. Ogino, and J. Campbell The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth PLoS One 16 2008 e2020
33. G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilization in cell death Physiol Rev 87 2007 99 163 (Pubitemid 46209992)
34. A. Degterev, and J. Yuan Expansion and evolution of cell death programmes Nat Rev Mol Cell Biol 9 2008 378 390 (Pubitemid 351574200)
35. A.G. Letai Diagnosing and exploiting cancer's addiction to blocks in apoptosis Nat Rev Cancer 8 2008 121 132 (Pubitemid 351161322)
36. S. Shankar, I. Siddiqui, and R.K. Srivastava Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells Mol Cell Biochem 304 2007 273 285 (Pubitemid 47456876)
37. E. Madan, S. Prasad, P. Roy, J. George, and Y. Shukla Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells Biochem Biophys Res Commun 377 2008 1232 1237
38. H. Fawcett, J.S. Mader, M. Robichaud, C. Giacomantonio, and D.W. Hoskin Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells Int J Oncol 27 2005 1717 1726
39. J.H. Stewart, T.L. Tran, N. Levi, W.S. Tsai, D.S. Schrump, and D.M. Nguyen The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma J Surg Res 141 2007 120 131 (Pubitemid 46908724)
40. U. Wenzel, S. Kuntz, U.J. De Sousa, and H. Daniel Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions Int J Cancer 106 2003 666 675 (Pubitemid 36993389)
41. M.E. Juan, J.M. Planas, V. Ruiz-Gutierrez, H. Daniel, and U. Wenzel Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells Br J Nutr 100 2008 36 43
42. W.S. Jeong, I.W. Kim, R. Hu, and A.N. Kong Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line Pharm Res 21 2004 661 670
43. X. Gao, Y.X. Xu, G. Divine, N. Janakiraman, R.A. Chapman, and S.C. Gautam Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes J Nutr 132 2002 2076 2081 (Pubitemid 34742903)
44. L. Tessitore, A. Davit, I. Sarotto, and G. Caderni Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression Carcinogenesis 21 2000 1619 1622 (Pubitemid 30608219)
45. D. Colin, E. Limagne, S. Jeanningros, A. Jacquel, G. Lizard, and A. Athias Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells Cancer Prev Res 4 2011 1095 1106
46. L.E. Bröker, F.A. Kruyt, and G. Giaccone Cell death independent of caspases: a review Clin Cancer Res 11 2005 3155 3162 (Pubitemid 40627860)
47. N.F. Trincheri, G. Nicotra, C. Follo, R. Castino, and C. Isidoro Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D Carcinogenesis 28 2007 922 931 (Pubitemid 47072174)
48. J.W. Park, K.J. Woo, J.T. Lee, J.H. Lim, T.J. Lee, and S.H. Kim Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells Oncol Rep 18 2007 1269 1273
49. K.J. Woo, T.J. Lee, S.H. Lee, J.M. Lee, J.H. Seo, and Y.J. Jeong Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells Biochem Pharmacol 73 2007 68 76 (Pubitemid 44853935)
50. H.J. Um, J.H. Bae, J.W. Park, H. Suh, N.Y. Jeong, and Y.H. Yoo Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation Int J Oncol 36 2010 1007 1013
51. N.F. Trincheri, C. Follo, G. Nicotra, C. Peracchio, R. Castino, and C. Isidoro Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes Carcinogenesis 29 2008 381 389 (Pubitemid 351359678)
52. D.W. Rosenberg, C. Giardina, and T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis 30 2009 183 196
53. J.M. Uronis, and D.W. Threadgill Murine models of colorectal cancer Mamm Genome 20 2009 261 268
54. T. Takayama, T. Goji, T. Taniguchi, and A. Inoue Chemoprevention of colorectal cancer-experimental and clinical aspects J Med Invest 56 2009 1 5
55. M. Perse, and A. Cerar Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats J Biomed Biotechnol 2011 2011 473964
56. J. Raju Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer World J Gastroenterol 14 2008 6632 6635
57. G. Caderni, A.P. Femia, A. Gianninni, A. Favuzza, C. Luceri, and M. Salvadori Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis Cancer Res 63 2003 2388 2392 (Pubitemid 36605173)
58. A.P. Femia, and G. Caderni Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products Planta Med 74 2008 1602 1607
59. I. Alfaras, M.E. Juan, and J.M.E. Planas trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats J Agric Food Chem 58 2010 8104 8110
60. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377 1382 (Pubitemid 39564557)
61. L.A. Stivala, M. Savio, F. Carafoli, P. Perucca, L. Bianchi, and G. Maga Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol J Biol Chem 276 2001 22586 22594
62. V. Cardile, L. Lombardo, C. Spatafora, and C. Tringali Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues Bioorg Chem 33 2005 22 33 (Pubitemid 40164184)
63. M. Sengottuvelan, P. Viswanathan, and N. Nalini Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis Carcinogenesis 27 2006 1038 1046
64. M. Sengottuvelan, K. Deeptha, and N. Nalini Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis Nutrition 25 2009 1169 1176
65. M. Sengottuvelan, K. Deeptha, and N. Nalini Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis Chem Biol Interact 181 2009 193 201
66. F. Wolter, L. Turchanowa, and J. Stein Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos Carcinogenesis 24 2003 469 474 (Pubitemid 36432642)
67. S. Ulrich, A. Huwiler, S. Loitsch, H. Schmidt, and J.M. Stein De novo ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity Biochem Pharmacol 74 2007 281 289 (Pubitemid 46890810)
68. M. Sengottuvelan, R. Senthilkumar, and N. Nalini Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis Biochim Biophys Acta 1760 2006 1175 1183 (Pubitemid 43928257)
69. Y. Schneider, B. Duranton, F. Gosse, R. Schleiffer, N. Seiler, and F. Raul Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis Nutr Cancer 39 2001 102 107 (Pubitemid 32880955)
70. C.C. Ziegler, L. Rainwater, J. Whelan, and M.F. McEntee Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice J Nutr 134 2004 5 10 (Pubitemid 38057415)
71. S. Sale, R.G. Tunstall, K.C. Ruparelia, G.A. Potter, W.P. Steward, and A.J. Gescher Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells Int J Cancer 115 2005 194 201 (Pubitemid 40586727)
72. A.V. Nguyen, M. Martinez, M.J. Stamos, M.P. Moyer, K. Planutis, and C. Hope Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer Cancer Manage Res 1 2009 25 37
73. K.R. Patel, V.A. Brown, D.J. Jones, R.G. Britton, D. Hemingway, and A.S. Miller Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients Cancer Res 70 2010 7392 7399
74. D.J. Boocock, G.E. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, and M.P. Ducharme Phase I dose escalation PK study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol Biomark Prev 16 2007 1246 1252 (Pubitemid 46984966)